Thrombin Induced Pulmonary Vascular Permeability

凝血酶诱导的肺血管通透性

基本信息

  • 批准号:
    7067620
  • 负责人:
  • 金额:
    $ 38.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-06-11 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We will extend our studies of the cellular and molecular mechanisms that are responsible for increased permeability of the lung vasculature. This increase in lung vascular permeability results in an array of pathological conditions including Adult Respiratory Distress Syndrome. The studies proposed here are based on the hypothesis that the VEcadherin- containing adherens junctions (AJs) of endothelial cells are critical determinants in both the increased permeability response of the endothelium and its time-dependent reversal. The dynamic AJ affects cell shape through the interaction of VE-cadherin with catenins that in turn associate with the actin cytoskeleton. The proposed studies will characterize the mechanisms by which AJs disassemble in response to thrombin and subsequently reassemble in a time-dependent manner. We will identify the phosphorylation and dephosphorylation "switches", present in the VEcadherin/ eatenin complexes, which are responsible for regulating endothelial permeability. This project has the following Aims: (i) to identify the signaling mechanisms mediating the loss of homotypic VE-cadherin binding, the disassembly of AJs, and the resultant increased permeability of the endothelium, (ii), to characterize the signaling mechanisms responsible for re-assembly of AJs and reversal of this increased permeability response, and (iii) to characterize the mechanism of angiopoietin-1-induced AJ stabilization and its role in inhibiting the loss of endothelial barrier function. The studies will be carried out both in endothelial cells and in vivo with intact mice. We will exploit a variety of methodologies including cell imaging, expression of mutant constructs, gene transfer, and the evaluation of transgenic mouse models. By more fully understanding mechanisms of increased vascular permeability and the reversal of this process, we will be in a position to develop novel strategies directed against components of the AJ complex that will prevent vascular leakiness and the formation of pulmonary edema.
描述(由申请人提供): 我们将扩展对导致肺脉管系统渗透性增加的细胞和分子机制的研究。肺血管通透性的增加导致一系列病理状况,包括成人呼吸窘迫综合征。这里提出的研究基于以下假设:在内皮细胞的内皮细胞中含有粘膜蛋白 - 含有粘附蛋白的连接(AJ)都是重要的决定因素,而内皮的渗透性响应及其时间依赖性逆转。动态AJ通过VE-钙粘着蛋白与Catenin的相互作用影响细胞形状,而Catenin又与肌动蛋白细胞骨架相关。拟议的研究将表征AJS响应凝血酶并随后以时间依赖性方式重新组装的机制。我们将确定存在于维卡德蛋白/ Eatenin络合物中的磷酸化和去磷酸化的“开关”,这些磷酸化和磷酸化蛋白复合物负责调节内皮渗透性。 This project has the following Aims: (i) to identify the signaling mechanisms mediating the loss of homotypic VE-cadherin binding, the disassembly of AJs, and the resultant increased permeability of the endothelium, (ii), to characterize the signaling mechanisms responsible for re-assembly of AJs and reversal of this increased permeability response, and (iii) to characterize the mechanism of血管生成素1诱导的AJ稳定及其在抑制内皮屏障功能丧失中的作用。这些研究将在内皮细胞和完整小鼠的体内进行。我们将利用各种方法,包括细胞成像,突变构建体的表达,基因转移以及转基因小鼠模型的评估。通过更充分了解增加的血管通透性的机制和该过程的逆转,我们将有能力开发针对AJ复合物组件的新型策略,以防止血管泄漏和肺水肿的形成。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Asrar B. Malik其他文献

Tissue Regeneration Requires Edema Fluid Clearance by Compensatory Lymphangiogenesis in Zebrafish
斑马鱼的组织再生需要通过补偿性淋巴管生成清除水肿液
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Olamide Olayinka;Hannah Ryu;Xiaowei Wang;Asrar B. Malik;Hyun Min Jung
  • 通讯作者:
    Hyun Min Jung
H<sub>2</sub>O<sub>2</sub> and Tumor Necrosis Factor-α Activate Intercellular Adhesion Molecule 1 (ICAM-1) Gene Transcription through Distinct <em>cis</em>-Regulatory Elements within the ICAM-1 Promoter
  • DOI:
    10.1074/jbc.270.32.18966
  • 发表时间:
    1995-08-11
  • 期刊:
  • 影响因子:
  • 作者:
    Kenneth A. Roebuck;Arshad Rahman;Venkatesh Lakshminarayanan;Kilambi Janakidevi;Asrar B. Malik
  • 通讯作者:
    Asrar B. Malik
The GTPase Rab1 Is Required for NLRP3 Inflammasome Activation and Inflammatory Lung Injury
GTPase Rab1 是 NLRP3 炎症小体激活和炎症性肺损伤所必需的
  • DOI:
    10.4049/jimmunol.1800777
  • 发表时间:
    2018-11
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Yuehui Zhang;Lijun Wang;Yang Lv;Chunling Jiang;Guangyu Wu;R;al O. Dull;Richard D. Minshall;Asrar B. Malik;Guochang Hu
  • 通讯作者:
    Guochang Hu
62 - NOSl-Derived Nitric Oxide Promotes NF-kB Transcriptional Activity Through Inhibition of Suppressor of Cytokine Signaling (SOCS-1)
  • DOI:
    10.1016/j.freeradbiomed.2015.10.101
  • 发表时间:
    2015-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Marcelo G Bonini;Sofia V Zaichik;Mao Mao;Peter C Hart;Saurabh Chatterjee;Asrar B. Malik;John W Christman;Michelle L. Block;Richard D Minshall;Benjamin N Gantner
  • 通讯作者:
    Benjamin N Gantner
Nitroglycerin-Induced Loss of Caveolin-1 Results in ENOS Dysfunction and Nitrate Tolerance
  • DOI:
    10.1016/j.freeradbiomed.2012.10.503
  • 发表时间:
    2012-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Mao Mao;Varadarajan Sudhahar;Tohru Fukai;Farnaz R. Bakhshi;Susan Varghese;Olga Chernaya;Xiaopei Gao;Asrar B. Malik;Richard D. Minshall;Samuel C. Dudley;Marcelo G. Bonini
  • 通讯作者:
    Marcelo G. Bonini

Asrar B. Malik的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Asrar B. Malik', 18)}}的其他基金

iPSC-Derived Vascularized Human Lung Organoids and Interaction Between Lung Endothelial Cells and Alveolar Epithelial Cells
iPSC 衍生的血管化人肺类器官以及肺内皮细胞和肺泡上皮细胞之间的相互作用
  • 批准号:
    10467249
  • 财政年份:
    2022
  • 资助金额:
    $ 38.05万
  • 项目类别:
Mechanisms and Treatment of SARS-CoV-2 induced Lung Endothelial Injury
SARS-CoV-2引起的肺内皮损伤的机制和治疗
  • 批准号:
    10559640
  • 财政年份:
    2022
  • 资助金额:
    $ 38.05万
  • 项目类别:
iPSC-Derived Vascularized Human Lung Organoids and Interaction Between Lung Endothelial Cells and Alveolar Epithelial Cells
iPSC 衍生的血管化人肺类器官以及肺内皮细胞和肺泡上皮细胞之间的相互作用
  • 批准号:
    10673199
  • 财政年份:
    2022
  • 资助金额:
    $ 38.05万
  • 项目类别:
E3 Ubiquitin Ligase CHFR Regulates Lung Endothelial Barrier Integrity and Innate Immunity through Control of VE-cadherin Expression
E3 泛素连接酶 CHFR 通过控制 VE-钙粘蛋白表达来调节肺内皮屏障完整性和先天免疫
  • 批准号:
    10706515
  • 财政年份:
    2022
  • 资助金额:
    $ 38.05万
  • 项目类别:
E3 Ubiquitin Ligase CHFR Regulates Lung Endothelial Barrier Integrity and Innate Immunity through Control of VE-cadherin Expression
E3 泛素连接酶 CHFR 通过控制 VE-钙粘蛋白表达来调节肺内皮屏障完整性和先天免疫
  • 批准号:
    10494617
  • 财政年份:
    2022
  • 资助金额:
    $ 38.05万
  • 项目类别:
Mechanisms and Treatment of SARS-CoV-2 induced Lung Endothelial Injury
SARS-CoV-2引起的肺内皮损伤的机制和治疗
  • 批准号:
    10390863
  • 财政年份:
    2022
  • 资助金额:
    $ 38.05万
  • 项目类别:
Amplification Mechanisms of Lung Endothelial Inflammation During Acute Lung Injury
急性肺损伤期间肺内皮炎症的放大机制
  • 批准号:
    10435435
  • 财政年份:
    2021
  • 资助金额:
    $ 38.05万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10491051
  • 财政年份:
    2021
  • 资助金额:
    $ 38.05万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10701924
  • 财政年份:
    2021
  • 资助金额:
    $ 38.05万
  • 项目类别:
Ion Flux Regulation of Macrophage Plasticity in Lung Injury and Repair
肺损伤与修复中巨噬细胞可塑性的离子通量调节
  • 批准号:
    10701929
  • 财政年份:
    2021
  • 资助金额:
    $ 38.05万
  • 项目类别:

相似国自然基金

血管生成素1诱导BMSCs成脂分化在CML耐药中的作用与机制研究
  • 批准号:
    82360732
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
血管生成素样蛋白2调控炎症和糖脂代谢促进糖尿病心肌病的机制研究
  • 批准号:
    82370356
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
潘氏细胞来源的血管生成素调控肠道干细胞促进肠上皮再生的作用机制
  • 批准号:
    82370557
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
血管生成素样蛋白4在间歇性低氧加重缺血性心肌损伤中的作用及机制研究
  • 批准号:
    82300379
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
血管生成素在胰腺炎致胰岛功能损伤中的保护作用及机制
  • 批准号:
    82270670
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目

相似海外基金

Regulation of vascular maturation/regression in diabetes
糖尿病血管成熟/退化的调节
  • 批准号:
    8588964
  • 财政年份:
    2010
  • 资助金额:
    $ 38.05万
  • 项目类别:
Regulation of vascular maturation/regression in diabetes
糖尿病血管成熟/退化的调节
  • 批准号:
    8110087
  • 财政年份:
    2010
  • 资助金额:
    $ 38.05万
  • 项目类别:
Regulation of vascular maturation/regression in diabetes
糖尿病血管成熟/退化的调节
  • 批准号:
    7992095
  • 财政年份:
    2010
  • 资助金额:
    $ 38.05万
  • 项目类别:
Molecular mechanisms of phospholipid metabolism and cell morphology regulated by small G protein signaling
小G蛋白信号调节磷脂代谢和细胞形态的分子机制
  • 批准号:
    17079008
  • 财政年份:
    2005
  • 资助金额:
    $ 38.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
脂質成長因子受容体EDG-1の血管内皮における発現調節機構の解析
血管内皮脂质生长因子受体EDG-1表达调控机制分析
  • 批准号:
    15790119
  • 财政年份:
    2003
  • 资助金额:
    $ 38.05万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了